Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei A Gakh

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|February 4, 2014
Trifluoromethylated heterocyclesAndrei A Gakh, Yuriy Shermolovich
Journal of the American Chemical Society|June 26, 2003
Thermodynamic rearrangement synthesis and NMR structures of C1, C3, and T isomers of C60H36Andrei A Gakh, Andrew Yu Romanovich, Ad Bax
Molecules (Basel, Switzerland)|October 27, 2007
A Java chemical structure editor supporting the Modular Chemical Descriptor Language (MCDL)Sergei V Trepalin, Alexander V Yarkov, Igor V Pletnev, et al.
Journal of Cheminformatics|February 1, 2011
Modular Chemical Descriptor Language (MCDL): Stereochemical modulesAndrei A Gakh, Michael N Burnett, Sergei V Trepalin, et al.
Molecules (Basel, Switzerland)|March 26, 2010
Synthesis of 1-(4-trifluoromethoxyphenyl)-2,5-dimethyl-3-(2-R-thiazol-4-yl)-1H-pyrroles via chain heterocyclizationMykhaylo V Vovk, Oleksandr M Pinchuk, Andrij O Tolmachov, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazoleAndrei A Gakh, Andrey V Sosnov, Mikhail Krasavin, et al.
Chemistry Central Journal|December 22, 2011
Trans-, cis-, and dihydro-resveratrol: a comparative studyNatalia Yu Anisimova, Mikhail V Kiselevsky, Andrey V Sosnov, et al.
Chemistry Central Journal|March 11, 2010
Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancerMikhail Krasavin, Konstantin A Rufanov, Andrey V Sosnov, et al.
Archiv Der Pharmazie|June 23, 2009
Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancerMikhail Krasavin, Ruben Karapetian, Igor Konstantinov, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2014
Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotypeMikhail Krasavin, Andrey V Sosnov, Ruben Karapetian, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|February 4, 2014
Trifluoromethylated heterocyclesAndrei A Gakh, Yuriy Shermolovich
Journal of the American Chemical Society|June 26, 2003
Thermodynamic rearrangement synthesis and NMR structures of C1, C3, and T isomers of C60H36Andrei A Gakh, Andrew Yu Romanovich, Ad Bax
Molecules (Basel, Switzerland)|October 27, 2007
A Java chemical structure editor supporting the Modular Chemical Descriptor Language (MCDL)Sergei V Trepalin, Alexander V Yarkov, Igor V Pletnev, et al.
Journal of Cheminformatics|February 1, 2011
Modular Chemical Descriptor Language (MCDL): Stereochemical modulesAndrei A Gakh, Michael N Burnett, Sergei V Trepalin, et al.
Molecules (Basel, Switzerland)|March 26, 2010
Synthesis of 1-(4-trifluoromethoxyphenyl)-2,5-dimethyl-3-(2-R-thiazol-4-yl)-1H-pyrroles via chain heterocyclizationMykhaylo V Vovk, Oleksandr M Pinchuk, Andrij O Tolmachov, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazoleAndrei A Gakh, Andrey V Sosnov, Mikhail Krasavin, et al.
Chemistry Central Journal|December 22, 2011
Trans-, cis-, and dihydro-resveratrol: a comparative studyNatalia Yu Anisimova, Mikhail V Kiselevsky, Andrey V Sosnov, et al.
Chemistry Central Journal|March 11, 2010
Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancerMikhail Krasavin, Konstantin A Rufanov, Andrey V Sosnov, et al.
Archiv Der Pharmazie|June 23, 2009
Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancerMikhail Krasavin, Ruben Karapetian, Igor Konstantinov, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2014
Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotypeMikhail Krasavin, Andrey V Sosnov, Ruben Karapetian, et al.
Pageof 2